Long-term Outcomes of Conservative Management in Patients with Moyamoya Disease and Their First-degree Relatives
The purpose of this study is to investigate the long-term outcomes of conservative management in patients with moyamoya disease and their first-degree relatives, and provide potential pathogenesis of moyamoya disease.
• Patients with age between 2-60 years;
• A clinical diagnosis of moyamoya disease, including unilateral and bilateral disease.
• Patients are medically treated with antiplatelets, antiepileptics, antihypertensives and vasodilators depending on the presentation.
• Capable of understanding the purpose and risk of the study and has signed the informed consent. If the participant is not capable of this at the time of enrollment, a legally authorized representative will provide written informed consent in accordance with all regulations.
• Ability to comply with study follow-up.